Physician profile
Angela Winn Ewing
NPI 1801885942
$2,075.44
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $113 · 2022: $405 · 2023: $1,011 · 2024: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,557.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $270.40 | 2023-2024 | |
| Mdd US Operations, LLC | $212.92 | 2024 | Gocovri |
| Abbvie INC. | $207.73 | 2021-2024 | |
| Biogen, INC. | $182.56 | 2022-2024 | Tysabri, Vumerity, Avonex |
| Ucb, INC. | $175.60 | 2023-2024 | Briviact, Rystiggo |
| Biohaven Pharmaceutical Holding Company LTD. | $132.18 | 2022 | |
| Sumitomo Pharma America, INC. | $100.42 | 2023-2024 | Aptiom |
| W. L. Gore & Associates, INC. | $85.90 | 2021 | |
| Celgene Corporation | $79.81 | 2022-2023 | Zeposia |
| Teva Pharmaceuticals USA, INC. | $66.59 | 2023-2024 | Austedo Xr, Austedo |
| Sk Life Science, INC. | $63.49 | 2022-2024 | |
| Argenx US, INC. | $54.79 | 2023 | Vyvgart Hytrulo, Vyvgart |
| Lundbeck LLC | $48.62 | 2022-2024 | Vyepti |
| Eisai INC. | $47.56 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $45.71 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $44.55 | 2022-2023 | Enspryng, Ocrevus |
| Amgen INC. | $44.30 | 2021-2023 | Aimovig |
| Sunovion Pharmaceuticals INC. | $40.26 | 2022 | |
| Corium, LLC | $35.09 | 2022-2023 | Adlarity |
| Si-Bone, INC. | $30.86 | 2023 | |
| Lilly USA, LLC | $30.76 | 2023-2024 | Amyvid |
| Amneal Pharmaceuticals LLC | $26.22 | 2023 | Rytary |
| Cala Health, INC. | $17.25 | 2023 | Cala Trio |
| Upsher-Smith Laboratories LLC | $16.24 | 2022 | |
| Neurocrine Biosciences, INC. | $15.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Ewing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.